Radiation — Induced Genetic Damage and the Prostaglandin System

Part of the Prostaglandins, Leukotrienes, and Cancer book series (PLAC, volume 5)


Radiation is one of the sheet anchors of cancer therapy. More often than not radiation is used in combination with anticancer drugs and surgery in the management of cancer. The death of any cell can be observed if the dose of radiation to which it is exposed is sufficiently high. However, after low doses of radiation (precise values vary with the tissue) disturbances in cell proliferation can be observed which may include interference with mitosis and DNA synthesis. This can lead to the formation of cells with abnormal DNA, with qualitative and/ or quantitative abnormalities. These effects of radiation are seen mainly in the tissues undergoing continual renewal such as mucosa, bone marrow, gonads etc., and the spectrum of damage ranging from progressive hypoplesia to total atrophy, depending on the dose. One of the late effects of radiation is the development of cancer.


Arachidonic Acid Free Radical Generation Bone Marrow Suppression Genetic Damage Genotoxic Action 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Allen, J.B., Sagerman, R.H., Stuart, M.J. Lancet. ii: 1193–1196, 1081.Google Scholar
  2. 2.
    Setty, B.N.Y., Jurek, E., Ganley, C., Stuart, M.J. Prostaglandins. Leukotrienes. Med. 14: 205–213, 1984.CrossRefGoogle Scholar
  3. 3.
    Polgar, P., Taylor, L. Prostaglandins, 19: 693–700, 1980.PubMedCrossRefGoogle Scholar
  4. 4.
    Das, U.N. Med. Hypotheses. 11: 185–194, 1983.PubMedCrossRefGoogle Scholar
  5. 5.
    Horrobin, D.F. Med. Hypotheses, 6: 687–709, 1980.PubMedCrossRefGoogle Scholar
  6. 6.
    Das, U.N., Devi, G.R., Rao, K.P., Rao, M.S. Prostaglandins. 29: 911–920, 1985.PubMedCrossRefGoogle Scholar
  7. 7.
    Das, U.N., Devi, G.R., Rao, K.P., Rao, M.S. Nutrit. Res. 5: 101–105, 1985.CrossRefGoogle Scholar
  8. 8.
    Das, U.N., Devi G.R., Rao, K.P., Rao, M.S. IRCS. Med.Sci.11:863–864, 1983.Google Scholar
  9. 9.
    Das, U.N. IRCS. Med.Sci.11:300–301, 1983.Google Scholar
  10. 10.
    Devi, G.R., Das, U.N., Rao, K.P., Rao, M.S.prostaglandins. Leukotrienes. Med. 15:109–113, 1984.CrossRefGoogle Scholar
  11. 11.
    Perry, P.E., Wolff, S.Nature, 251:156–158, 1974.CrossRefGoogle Scholar
  12. 12.
    Schmid, W. Mutation. Res.31:9–15, 1975.PubMedGoogle Scholar
  13. 13.
    Bailey, J.M.In; Lipid metabolism in mammals (Ed.F. Snyder), Plenumpress, New York, Vol.2, 1977, P 352.Google Scholar
  14. 14.
    Deby, C., and Deby-Dupont, G.In: Biological and clinical aspects of superoxide and superoxide dismutase (Eds.W.H. Bannister and J.V. Bannister), Proc.Fed.Eur.Biochem.Soc.Symposium No:62, 1982, P 84–97.Google Scholar
  15. 15.
    Birnboim, H.C.Science. 215:1247–1249, 1982.PubMedCrossRefGoogle Scholar
  16. 16.
    Das, U.N.Int.J.Tiss.Reac. 2:233–236, 1980.Google Scholar
  17. 17.
    Das, U.N.Int.J.Tiss.Reac. 3:89–93, 1981.Google Scholar
  18. 18.
    Emerit, I., Levy, A., Cerutti, P.Mutation.Res.110:327–335, 1983.PubMedCrossRefGoogle Scholar
  19. 19.
    Sedgmck, J.B., Berube, M.L., Zurier, R.B.Clin.Immunol. Immunopathol. 34: 205–215, 1985.CrossRefGoogle Scholar
  20. 20.
    Penfield, A., Dale, M.M.FEBS.Lett.181: 335–338, 1985.PubMedCrossRefGoogle Scholar
  21. 21.
    Bennett, A., Carroll, M.A., Stamford, I.F., et al.Br.J.Pharmacol. 74:207–212, 1981.Google Scholar
  22. 22.
    Levine, L.Adv.Cancer. Res.35:49–79, 1981.PubMedCrossRefGoogle Scholar
  23. 23.
    Levine, L. Nature. 268:447–448, 1977.PubMedCrossRefGoogle Scholar
  24. 24.
    Rowley, J.D. Nature. 301: 290–291, 1983.PubMedCrossRefGoogle Scholar
  25. 25.
    Rowley, J.D. Nature. 308:607–608, 1984.PubMedCrossRefGoogle Scholar
  26. 26.
    Das, U.N. Speculations. Sci. Tech. 9:99–102, 1986.Google Scholar
  27. 27.
    Das, U.N., Devi, G.R., Rao, K.P. IRCS. Med.Sci. 13: 316–317, 1985.Google Scholar
  28. 28.
    Begin, M.E., Das, U.N., Ells, G., Horrobin, D.F. Prostaglandins. Leukotrienes. Med. 19: 177–186, 1985.CrossRefGoogle Scholar
  29. 29.
    Das, U.N., Huang, Y.S., Begin, M.E., Horrobin, D.F. IRCS. J.Med.Sci. in press.Google Scholar
  30. 30.
    Das, U.N., Ells, G., Begin, M.E., Horrobin, D.F. J.Free. Radicals. Biol. Med. in press.Google Scholar
  31. Das, U.N., et al. J. Free. Radicals. Biol. Med. in press.Google Scholar
  32. Das, U.N., et al. IRCS J. Med. Sci., in press (1986).Google Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1988

Authors and Affiliations

  1. 1.Department of Clinical Pharmacology and Medical ResearchNizam’s Institute of Medical SciencesPunjagutta, HyderabadIndia

Personalised recommendations